Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05047926 · ClinicalTrials.gov registry record · NA
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT05047926: Completed NA study, sponsored by Mayo Clinic.
NCT05047926 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05047926, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This clinical trial evaluates whether a prehabilitation program started at the time of neoadjuvant chemotherapy will affect surgical recovery in patients with stage IIIC-IV ovarian, fallopian tube, or primary peritoneal cancer. A prehabilitation program may improve the quality of life after surgery for patients with ovarian, fallopian tube, or primary peritoneal cancer.
Interventions
- PROCEDURE Computed Tomography
- OTHER Survey Administration
- OTHER Physical Activity
- BEHAVIORAL Behavioral Counseling
- DIETARY_SUPPLEMENT Nutritional Supplement Drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2021-10-05 |
| Est. Completion | 2025-07-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05047926
The ClinicalTrials.gov registry entry for NCT05047926 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Computed Tomography is the first listed.
NCT05047926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05047926 about?
NCT05047926 is a clinical study titled "Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients". This clinical trial evaluates whether a prehabilitation program started at the time of neoadjuvant chemotherapy will affect surgical recovery in patients with stage IIIC-IV ovarian, fallopian tube, or primary peritoneal cancer. A prehabilitation program may improve the quality of life after surgery ...
What is the current status of trial NCT05047926?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2021-10-05. Estimated completion is 2025-07-08.
What interventions are being tested in trial NCT05047926?
The interventions under investigation include: Computed Tomography (PROCEDURE), Survey Administration (OTHER), Physical Activity (OTHER), Behavioral Counseling (BEHAVIORAL), Nutritional Supplement Drink (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05047926?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.